ReviewMolecular biology reports2022
CRISPR/Cas9 mediated genome editing tools and their possible role in disease resistance mechanism.
Review in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fostering plant growth performance under drought stress using rhizospheric microbes, their gene editing, and biochar.Environmental geochemistry and health · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several phytopathogens have detrimental effects on crop production and productivity potentially threatening global food security. Studying the genetic mechanisms of virulence in phytopathogens is vital to assist in their management. Genome editing tools are paving their fascinating roles from the first-generation site-specific nucleases ZNF and TALEN to the current generation clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein9. The discovery of CRISPR/Cas9 has revolutionised the understanding of resistance as well as the susceptibility mechanism against phytopathogens in crop plants. This emerging tool allows researchers to perform precise genome manipulation, genetic screening, regulation, and correction to develop resistance in crop plants with fewer off-target effects. It provides a new opportunity for disease improvement and strengthens the resistant breeding programme. CRISPR/Cas9-based targeted gene manipulation and its enormous application potential as well as the challenges for developing transgene-free disease-resistant crop plants have been discussed in this review.
Indexed as
Identifiers
36104588What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.